Document is current
Any future updates will be listed below
-
Authors
Itami, Kanji
Kimoto, Keitaro
Takahashi, Yuki
Onishi, Yuichi
Mikami, Katsunaka
Yamamoto, Kenji
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 8 December 2025
First Online: 25 December 2025
Declarations
:
: Not applicable.
: Written informed consent was obtained from the patients and their families for this publication.
: Kanji Itami declares no competing interests.Keitaro Kimoto has received research grants from Otsuka Pharmaceutical Co., Ltd. and Shionogi & Co., Ltd., and honoraria from Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Viatris Inc.Yuki Takahashi has received research grants from Shionogi & Co., Ltd.Yuichi Onishi has received research grants and honoraria from Takeda Pharmaceutical Co., Ltd.Katsunaka Mikami has received financial support from Shionogi & Co., Ltd.; honoraria from Shionogi & Co., Ltd., Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Otsuka Pharmaceutical Co., Ltd.; travel and accommodation expenses from Otsuka Pharmaceutical Co., Ltd.; and consulting fees from Shionogi & Co., Ltd., EA Pharma Co., Ltd., Sumitomo Pharma Co., Ltd., and Otsuka Pharmaceutical Co., Ltd.Kenji Yamamoto has received grants and personal fees from Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Shionogi & Co., Ltd.; personal fees from Meiji Seika Pharma Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Merck Sharp & Dohme, Viatris Inc., Takeda Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Lundbeck Japan K.K., Daiichi Sankyo Co., Ltd., and OCTAWELL Co., Ltd.; and research support from JSPS KAKENHI (Grant Number 22K07588), outside the submitted work.
